nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCG2—Dactinomycin—testicular cancer	0.0842	0.118	CbGbCtD
Venlafaxine—CYP2B6—Ifosfamide—testicular cancer	0.0699	0.0981	CbGbCtD
Venlafaxine—ABCG2—Carboplatin—testicular cancer	0.0566	0.0794	CbGbCtD
Venlafaxine—ABCG2—Cisplatin—testicular cancer	0.0484	0.0679	CbGbCtD
Venlafaxine—ABCG2—Etoposide—testicular cancer	0.0475	0.0667	CbGbCtD
Venlafaxine—CYP2C19—Ifosfamide—testicular cancer	0.0444	0.0624	CbGbCtD
Venlafaxine—CYP2C9—Ifosfamide—testicular cancer	0.0369	0.0518	CbGbCtD
Venlafaxine—CYP2B6—Cisplatin—testicular cancer	0.034	0.0477	CbGbCtD
Venlafaxine—ABCG2—Doxorubicin—testicular cancer	0.0324	0.0455	CbGbCtD
Venlafaxine—ABCG2—Methotrexate—testicular cancer	0.0314	0.0441	CbGbCtD
Venlafaxine—ABCB1—Dactinomycin—testicular cancer	0.0304	0.0426	CbGbCtD
Venlafaxine—CYP2B6—Doxorubicin—testicular cancer	0.0228	0.032	CbGbCtD
Venlafaxine—CYP3A4—Ifosfamide—testicular cancer	0.0215	0.0301	CbGbCtD
Venlafaxine—ABCB1—Vinblastine—testicular cancer	0.019	0.0267	CbGbCtD
Venlafaxine—CYP2C9—Cisplatin—testicular cancer	0.018	0.0252	CbGbCtD
Venlafaxine—CYP2D6—Vinblastine—testicular cancer	0.0179	0.0251	CbGbCtD
Venlafaxine—ABCB1—Cisplatin—testicular cancer	0.0174	0.0245	CbGbCtD
Venlafaxine—ABCB1—Etoposide—testicular cancer	0.0171	0.024	CbGbCtD
Venlafaxine—ABCB1—Doxorubicin—testicular cancer	0.0117	0.0164	CbGbCtD
Venlafaxine—CYP3A4—Vinblastine—testicular cancer	0.0114	0.016	CbGbCtD
Venlafaxine—ABCB1—Methotrexate—testicular cancer	0.0113	0.0159	CbGbCtD
Venlafaxine—CYP2D6—Doxorubicin—testicular cancer	0.011	0.0155	CbGbCtD
Venlafaxine—CYP3A4—Etoposide—testicular cancer	0.0103	0.0144	CbGbCtD
Venlafaxine—CYP3A4—Doxorubicin—testicular cancer	0.007	0.00983	CbGbCtD
Venlafaxine—NPY1R—seminal vesicle—testicular cancer	0.000141	0.194	CbGeAlD
Venlafaxine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000104	0.000363	CcSEcCtD
Venlafaxine—Weight increased—Doxorubicin—testicular cancer	0.000104	0.000362	CcSEcCtD
Venlafaxine—Epistaxis—Epirubicin—testicular cancer	0.000104	0.000362	CcSEcCtD
Venlafaxine—Weight decreased—Doxorubicin—testicular cancer	0.000103	0.00036	CcSEcCtD
Venlafaxine—Sinusitis—Epirubicin—testicular cancer	0.000103	0.00036	CcSEcCtD
Venlafaxine—Feeling abnormal—Etoposide—testicular cancer	0.000103	0.00036	CcSEcCtD
Venlafaxine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000103	0.000359	CcSEcCtD
Venlafaxine—Nausea—Dactinomycin—testicular cancer	0.000103	0.000358	CcSEcCtD
Venlafaxine—Agranulocytosis—Epirubicin—testicular cancer	0.000103	0.000358	CcSEcCtD
Venlafaxine—Pneumonia—Doxorubicin—testicular cancer	0.000102	0.000357	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Etoposide—testicular cancer	0.000102	0.000357	CcSEcCtD
Venlafaxine—Visual impairment—Methotrexate—testicular cancer	0.000102	0.000355	CcSEcCtD
Venlafaxine—NPY1R—gonad—testicular cancer	0.000102	0.14	CbGeAlD
Venlafaxine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000101	0.000352	CcSEcCtD
Venlafaxine—Vomiting—Ifosfamide—testicular cancer	0.000101	0.000351	CcSEcCtD
Venlafaxine—Hypersensitivity—Cisplatin—testicular cancer	0.000101	0.000351	CcSEcCtD
Venlafaxine—Bradycardia—Epirubicin—testicular cancer	0.000101	0.000351	CcSEcCtD
Venlafaxine—Renal failure—Doxorubicin—testicular cancer	0.0001	0.000349	CcSEcCtD
Venlafaxine—Rash—Ifosfamide—testicular cancer	9.99e-05	0.000349	CcSEcCtD
Venlafaxine—Dermatitis—Ifosfamide—testicular cancer	9.98e-05	0.000348	CcSEcCtD
Venlafaxine—Erythema multiforme—Methotrexate—testicular cancer	9.98e-05	0.000348	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Doxorubicin—testicular cancer	9.98e-05	0.000348	CcSEcCtD
Venlafaxine—Urticaria—Etoposide—testicular cancer	9.94e-05	0.000347	CcSEcCtD
Venlafaxine—Haemoglobin—Epirubicin—testicular cancer	9.93e-05	0.000346	CcSEcCtD
Venlafaxine—Stomatitis—Doxorubicin—testicular cancer	9.92e-05	0.000346	CcSEcCtD
Venlafaxine—Jaundice—Doxorubicin—testicular cancer	9.92e-05	0.000346	CcSEcCtD
Venlafaxine—Rhinitis—Epirubicin—testicular cancer	9.9e-05	0.000345	CcSEcCtD
Venlafaxine—Abdominal pain—Etoposide—testicular cancer	9.89e-05	0.000345	CcSEcCtD
Venlafaxine—Body temperature increased—Etoposide—testicular cancer	9.89e-05	0.000345	CcSEcCtD
Venlafaxine—Conjunctivitis—Doxorubicin—testicular cancer	9.89e-05	0.000345	CcSEcCtD
Venlafaxine—Haemorrhage—Epirubicin—testicular cancer	9.88e-05	0.000344	CcSEcCtD
Venlafaxine—Hepatitis—Epirubicin—testicular cancer	9.88e-05	0.000344	CcSEcCtD
Venlafaxine—Tinnitus—Methotrexate—testicular cancer	9.84e-05	0.000343	CcSEcCtD
Venlafaxine—Hypoaesthesia—Epirubicin—testicular cancer	9.83e-05	0.000343	CcSEcCtD
Venlafaxine—Asthenia—Cisplatin—testicular cancer	9.8e-05	0.000342	CcSEcCtD
Venlafaxine—Pharyngitis—Epirubicin—testicular cancer	9.8e-05	0.000342	CcSEcCtD
Venlafaxine—Cardiac disorder—Methotrexate—testicular cancer	9.79e-05	0.000342	CcSEcCtD
Venlafaxine—Sweating—Doxorubicin—testicular cancer	9.76e-05	0.00034	CcSEcCtD
Venlafaxine—Haematuria—Doxorubicin—testicular cancer	9.7e-05	0.000339	CcSEcCtD
Venlafaxine—Epistaxis—Doxorubicin—testicular cancer	9.6e-05	0.000335	CcSEcCtD
Venlafaxine—Sinusitis—Doxorubicin—testicular cancer	9.55e-05	0.000333	CcSEcCtD
Venlafaxine—Visual impairment—Epirubicin—testicular cancer	9.52e-05	0.000332	CcSEcCtD
Venlafaxine—Agranulocytosis—Doxorubicin—testicular cancer	9.5e-05	0.000331	CcSEcCtD
Venlafaxine—Chills—Methotrexate—testicular cancer	9.47e-05	0.00033	CcSEcCtD
Venlafaxine—Nausea—Ifosfamide—testicular cancer	9.41e-05	0.000328	CcSEcCtD
Venlafaxine—Diarrhoea—Cisplatin—testicular cancer	9.35e-05	0.000326	CcSEcCtD
Venlafaxine—Erythema multiforme—Epirubicin—testicular cancer	9.34e-05	0.000326	CcSEcCtD
Venlafaxine—Alopecia—Methotrexate—testicular cancer	9.32e-05	0.000325	CcSEcCtD
Venlafaxine—Bradycardia—Doxorubicin—testicular cancer	9.3e-05	0.000324	CcSEcCtD
Venlafaxine—Hypersensitivity—Etoposide—testicular cancer	9.22e-05	0.000322	CcSEcCtD
Venlafaxine—Tinnitus—Epirubicin—testicular cancer	9.21e-05	0.000321	CcSEcCtD
Venlafaxine—Erythema—Methotrexate—testicular cancer	9.19e-05	0.00032	CcSEcCtD
Venlafaxine—Haemoglobin—Doxorubicin—testicular cancer	9.18e-05	0.00032	CcSEcCtD
Venlafaxine—Flushing—Epirubicin—testicular cancer	9.16e-05	0.00032	CcSEcCtD
Venlafaxine—Cardiac disorder—Epirubicin—testicular cancer	9.16e-05	0.00032	CcSEcCtD
Venlafaxine—Rhinitis—Doxorubicin—testicular cancer	9.16e-05	0.00032	CcSEcCtD
Venlafaxine—Haemorrhage—Doxorubicin—testicular cancer	9.14e-05	0.000319	CcSEcCtD
Venlafaxine—Hepatitis—Doxorubicin—testicular cancer	9.14e-05	0.000319	CcSEcCtD
Venlafaxine—Hypoaesthesia—Doxorubicin—testicular cancer	9.09e-05	0.000317	CcSEcCtD
Venlafaxine—Pharyngitis—Doxorubicin—testicular cancer	9.07e-05	0.000316	CcSEcCtD
Venlafaxine—Dysgeusia—Methotrexate—testicular cancer	9e-05	0.000314	CcSEcCtD
Venlafaxine—Asthenia—Etoposide—testicular cancer	8.98e-05	0.000313	CcSEcCtD
Venlafaxine—Back pain—Methotrexate—testicular cancer	8.89e-05	0.00031	CcSEcCtD
Venlafaxine—Chills—Epirubicin—testicular cancer	8.86e-05	0.000309	CcSEcCtD
Venlafaxine—Pruritus—Etoposide—testicular cancer	8.86e-05	0.000309	CcSEcCtD
Venlafaxine—Arrhythmia—Epirubicin—testicular cancer	8.82e-05	0.000308	CcSEcCtD
Venlafaxine—Visual impairment—Doxorubicin—testicular cancer	8.81e-05	0.000307	CcSEcCtD
Venlafaxine—Alopecia—Epirubicin—testicular cancer	8.73e-05	0.000304	CcSEcCtD
Venlafaxine—Vomiting—Cisplatin—testicular cancer	8.69e-05	0.000303	CcSEcCtD
Venlafaxine—Vision blurred—Methotrexate—testicular cancer	8.66e-05	0.000302	CcSEcCtD
Venlafaxine—Erythema multiforme—Doxorubicin—testicular cancer	8.64e-05	0.000301	CcSEcCtD
Venlafaxine—Rash—Cisplatin—testicular cancer	8.61e-05	0.0003	CcSEcCtD
Venlafaxine—Dermatitis—Cisplatin—testicular cancer	8.61e-05	0.0003	CcSEcCtD
Venlafaxine—Erythema—Epirubicin—testicular cancer	8.6e-05	0.0003	CcSEcCtD
Venlafaxine—Diarrhoea—Etoposide—testicular cancer	8.56e-05	0.000299	CcSEcCtD
Venlafaxine—Ill-defined disorder—Methotrexate—testicular cancer	8.52e-05	0.000297	CcSEcCtD
Venlafaxine—Tinnitus—Doxorubicin—testicular cancer	8.52e-05	0.000297	CcSEcCtD
Venlafaxine—Anaemia—Methotrexate—testicular cancer	8.49e-05	0.000296	CcSEcCtD
Venlafaxine—Cardiac disorder—Doxorubicin—testicular cancer	8.48e-05	0.000296	CcSEcCtD
Venlafaxine—Flushing—Doxorubicin—testicular cancer	8.48e-05	0.000296	CcSEcCtD
Venlafaxine—Flatulence—Epirubicin—testicular cancer	8.47e-05	0.000295	CcSEcCtD
Venlafaxine—Tension—Epirubicin—testicular cancer	8.44e-05	0.000294	CcSEcCtD
Venlafaxine—Dysgeusia—Epirubicin—testicular cancer	8.42e-05	0.000294	CcSEcCtD
Venlafaxine—Nervousness—Epirubicin—testicular cancer	8.35e-05	0.000291	CcSEcCtD
Venlafaxine—Back pain—Epirubicin—testicular cancer	8.32e-05	0.00029	CcSEcCtD
Venlafaxine—Malaise—Methotrexate—testicular cancer	8.28e-05	0.000289	CcSEcCtD
Venlafaxine—Dizziness—Etoposide—testicular cancer	8.28e-05	0.000289	CcSEcCtD
Venlafaxine—Muscle spasms—Epirubicin—testicular cancer	8.26e-05	0.000288	CcSEcCtD
Venlafaxine—Vertigo—Methotrexate—testicular cancer	8.25e-05	0.000288	CcSEcCtD
Venlafaxine—Leukopenia—Methotrexate—testicular cancer	8.22e-05	0.000287	CcSEcCtD
Venlafaxine—Chills—Doxorubicin—testicular cancer	8.2e-05	0.000286	CcSEcCtD
Venlafaxine—Arrhythmia—Doxorubicin—testicular cancer	8.16e-05	0.000285	CcSEcCtD
Venlafaxine—Nausea—Cisplatin—testicular cancer	8.11e-05	0.000283	CcSEcCtD
Venlafaxine—Vision blurred—Epirubicin—testicular cancer	8.1e-05	0.000283	CcSEcCtD
Venlafaxine—Alopecia—Doxorubicin—testicular cancer	8.07e-05	0.000282	CcSEcCtD
Venlafaxine—Cough—Methotrexate—testicular cancer	8.02e-05	0.00028	CcSEcCtD
Venlafaxine—Ill-defined disorder—Epirubicin—testicular cancer	7.98e-05	0.000278	CcSEcCtD
Venlafaxine—Convulsion—Methotrexate—testicular cancer	7.96e-05	0.000278	CcSEcCtD
Venlafaxine—Vomiting—Etoposide—testicular cancer	7.96e-05	0.000278	CcSEcCtD
Venlafaxine—Erythema—Doxorubicin—testicular cancer	7.95e-05	0.000277	CcSEcCtD
Venlafaxine—Anaemia—Epirubicin—testicular cancer	7.95e-05	0.000277	CcSEcCtD
Venlafaxine—Agitation—Epirubicin—testicular cancer	7.9e-05	0.000276	CcSEcCtD
Venlafaxine—Rash—Etoposide—testicular cancer	7.89e-05	0.000275	CcSEcCtD
Venlafaxine—Dermatitis—Etoposide—testicular cancer	7.88e-05	0.000275	CcSEcCtD
Venlafaxine—Headache—Etoposide—testicular cancer	7.84e-05	0.000274	CcSEcCtD
Venlafaxine—Flatulence—Doxorubicin—testicular cancer	7.84e-05	0.000273	CcSEcCtD
Venlafaxine—Arthralgia—Methotrexate—testicular cancer	7.82e-05	0.000273	CcSEcCtD
Venlafaxine—Chest pain—Methotrexate—testicular cancer	7.82e-05	0.000273	CcSEcCtD
Venlafaxine—Myalgia—Methotrexate—testicular cancer	7.82e-05	0.000273	CcSEcCtD
Venlafaxine—Tension—Doxorubicin—testicular cancer	7.81e-05	0.000272	CcSEcCtD
Venlafaxine—Dysgeusia—Doxorubicin—testicular cancer	7.79e-05	0.000272	CcSEcCtD
Venlafaxine—Malaise—Epirubicin—testicular cancer	7.75e-05	0.00027	CcSEcCtD
Venlafaxine—Discomfort—Methotrexate—testicular cancer	7.73e-05	0.00027	CcSEcCtD
Venlafaxine—Nervousness—Doxorubicin—testicular cancer	7.73e-05	0.000269	CcSEcCtD
Venlafaxine—Vertigo—Epirubicin—testicular cancer	7.72e-05	0.000269	CcSEcCtD
Venlafaxine—Syncope—Epirubicin—testicular cancer	7.71e-05	0.000269	CcSEcCtD
Venlafaxine—Leukopenia—Epirubicin—testicular cancer	7.69e-05	0.000268	CcSEcCtD
Venlafaxine—Back pain—Doxorubicin—testicular cancer	7.69e-05	0.000268	CcSEcCtD
Venlafaxine—Muscle spasms—Doxorubicin—testicular cancer	7.65e-05	0.000267	CcSEcCtD
Venlafaxine—Palpitations—Epirubicin—testicular cancer	7.6e-05	0.000265	CcSEcCtD
Venlafaxine—Confusional state—Methotrexate—testicular cancer	7.56e-05	0.000264	CcSEcCtD
Venlafaxine—Loss of consciousness—Epirubicin—testicular cancer	7.56e-05	0.000264	CcSEcCtD
Venlafaxine—Cough—Epirubicin—testicular cancer	7.5e-05	0.000262	CcSEcCtD
Venlafaxine—Anaphylactic shock—Methotrexate—testicular cancer	7.5e-05	0.000262	CcSEcCtD
Venlafaxine—Vision blurred—Doxorubicin—testicular cancer	7.5e-05	0.000261	CcSEcCtD
Venlafaxine—Convulsion—Epirubicin—testicular cancer	7.45e-05	0.00026	CcSEcCtD
Venlafaxine—Infection—Methotrexate—testicular cancer	7.45e-05	0.00026	CcSEcCtD
Venlafaxine—Nausea—Etoposide—testicular cancer	7.43e-05	0.000259	CcSEcCtD
Venlafaxine—Hypertension—Epirubicin—testicular cancer	7.42e-05	0.000259	CcSEcCtD
Venlafaxine—Ill-defined disorder—Doxorubicin—testicular cancer	7.38e-05	0.000257	CcSEcCtD
Venlafaxine—Anaemia—Doxorubicin—testicular cancer	7.35e-05	0.000256	CcSEcCtD
Venlafaxine—Thrombocytopenia—Methotrexate—testicular cancer	7.34e-05	0.000256	CcSEcCtD
Venlafaxine—NPY1R—testis—testicular cancer	7.32e-05	0.101	CbGeAlD
Venlafaxine—Myalgia—Epirubicin—testicular cancer	7.32e-05	0.000255	CcSEcCtD
Venlafaxine—Chest pain—Epirubicin—testicular cancer	7.32e-05	0.000255	CcSEcCtD
Venlafaxine—Arthralgia—Epirubicin—testicular cancer	7.32e-05	0.000255	CcSEcCtD
Venlafaxine—Agitation—Doxorubicin—testicular cancer	7.31e-05	0.000255	CcSEcCtD
Venlafaxine—Anxiety—Epirubicin—testicular cancer	7.29e-05	0.000254	CcSEcCtD
Venlafaxine—Hyperhidrosis—Methotrexate—testicular cancer	7.25e-05	0.000253	CcSEcCtD
Venlafaxine—Discomfort—Epirubicin—testicular cancer	7.23e-05	0.000252	CcSEcCtD
Venlafaxine—Malaise—Doxorubicin—testicular cancer	7.17e-05	0.00025	CcSEcCtD
Venlafaxine—Dry mouth—Epirubicin—testicular cancer	7.16e-05	0.00025	CcSEcCtD
Venlafaxine—Vertigo—Doxorubicin—testicular cancer	7.15e-05	0.000249	CcSEcCtD
Venlafaxine—Anorexia—Methotrexate—testicular cancer	7.15e-05	0.000249	CcSEcCtD
Venlafaxine—Syncope—Doxorubicin—testicular cancer	7.13e-05	0.000249	CcSEcCtD
Venlafaxine—Leukopenia—Doxorubicin—testicular cancer	7.12e-05	0.000248	CcSEcCtD
Venlafaxine—Confusional state—Epirubicin—testicular cancer	7.07e-05	0.000247	CcSEcCtD
Venlafaxine—Palpitations—Doxorubicin—testicular cancer	7.03e-05	0.000245	CcSEcCtD
Venlafaxine—Anaphylactic shock—Epirubicin—testicular cancer	7.02e-05	0.000245	CcSEcCtD
Venlafaxine—Oedema—Epirubicin—testicular cancer	7.02e-05	0.000245	CcSEcCtD
Venlafaxine—Hypotension—Methotrexate—testicular cancer	7.01e-05	0.000244	CcSEcCtD
Venlafaxine—Loss of consciousness—Doxorubicin—testicular cancer	6.99e-05	0.000244	CcSEcCtD
Venlafaxine—Infection—Epirubicin—testicular cancer	6.97e-05	0.000243	CcSEcCtD
Venlafaxine—Cough—Doxorubicin—testicular cancer	6.94e-05	0.000242	CcSEcCtD
Venlafaxine—Shock—Epirubicin—testicular cancer	6.9e-05	0.000241	CcSEcCtD
Venlafaxine—Convulsion—Doxorubicin—testicular cancer	6.89e-05	0.00024	CcSEcCtD
Venlafaxine—Thrombocytopenia—Epirubicin—testicular cancer	6.87e-05	0.00024	CcSEcCtD
Venlafaxine—Hypertension—Doxorubicin—testicular cancer	6.87e-05	0.00024	CcSEcCtD
Venlafaxine—Tachycardia—Epirubicin—testicular cancer	6.85e-05	0.000239	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Methotrexate—testicular cancer	6.83e-05	0.000238	CcSEcCtD
Venlafaxine—Hyperhidrosis—Epirubicin—testicular cancer	6.78e-05	0.000237	CcSEcCtD
Venlafaxine—Insomnia—Methotrexate—testicular cancer	6.78e-05	0.000237	CcSEcCtD
Venlafaxine—Myalgia—Doxorubicin—testicular cancer	6.77e-05	0.000236	CcSEcCtD
Venlafaxine—Arthralgia—Doxorubicin—testicular cancer	6.77e-05	0.000236	CcSEcCtD
Venlafaxine—Chest pain—Doxorubicin—testicular cancer	6.77e-05	0.000236	CcSEcCtD
Venlafaxine—Anxiety—Doxorubicin—testicular cancer	6.75e-05	0.000235	CcSEcCtD
Venlafaxine—Paraesthesia—Methotrexate—testicular cancer	6.73e-05	0.000235	CcSEcCtD
Venlafaxine—Discomfort—Doxorubicin—testicular cancer	6.69e-05	0.000233	CcSEcCtD
Venlafaxine—Anorexia—Epirubicin—testicular cancer	6.69e-05	0.000233	CcSEcCtD
Venlafaxine—Dyspnoea—Methotrexate—testicular cancer	6.68e-05	0.000233	CcSEcCtD
Venlafaxine—Somnolence—Methotrexate—testicular cancer	6.66e-05	0.000232	CcSEcCtD
Venlafaxine—Dry mouth—Doxorubicin—testicular cancer	6.62e-05	0.000231	CcSEcCtD
Venlafaxine—Dyspepsia—Methotrexate—testicular cancer	6.6e-05	0.00023	CcSEcCtD
Venlafaxine—Hypotension—Epirubicin—testicular cancer	6.56e-05	0.000229	CcSEcCtD
Venlafaxine—Confusional state—Doxorubicin—testicular cancer	6.55e-05	0.000228	CcSEcCtD
Venlafaxine—Decreased appetite—Methotrexate—testicular cancer	6.52e-05	0.000227	CcSEcCtD
Venlafaxine—Anaphylactic shock—Doxorubicin—testicular cancer	6.49e-05	0.000226	CcSEcCtD
Venlafaxine—Oedema—Doxorubicin—testicular cancer	6.49e-05	0.000226	CcSEcCtD
Venlafaxine—Fatigue—Methotrexate—testicular cancer	6.46e-05	0.000225	CcSEcCtD
Venlafaxine—Infection—Doxorubicin—testicular cancer	6.45e-05	0.000225	CcSEcCtD
Venlafaxine—Pain—Methotrexate—testicular cancer	6.41e-05	0.000224	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Epirubicin—testicular cancer	6.39e-05	0.000223	CcSEcCtD
Venlafaxine—Shock—Doxorubicin—testicular cancer	6.39e-05	0.000223	CcSEcCtD
Venlafaxine—Thrombocytopenia—Doxorubicin—testicular cancer	6.36e-05	0.000222	CcSEcCtD
Venlafaxine—Insomnia—Epirubicin—testicular cancer	6.35e-05	0.000221	CcSEcCtD
Venlafaxine—Tachycardia—Doxorubicin—testicular cancer	6.34e-05	0.000221	CcSEcCtD
Venlafaxine—Paraesthesia—Epirubicin—testicular cancer	6.3e-05	0.00022	CcSEcCtD
Venlafaxine—Hyperhidrosis—Doxorubicin—testicular cancer	6.28e-05	0.000219	CcSEcCtD
Venlafaxine—Dyspnoea—Epirubicin—testicular cancer	6.25e-05	0.000218	CcSEcCtD
Venlafaxine—Somnolence—Epirubicin—testicular cancer	6.24e-05	0.000218	CcSEcCtD
Venlafaxine—Anorexia—Doxorubicin—testicular cancer	6.19e-05	0.000216	CcSEcCtD
Venlafaxine—Feeling abnormal—Methotrexate—testicular cancer	6.18e-05	0.000215	CcSEcCtD
Venlafaxine—Dyspepsia—Epirubicin—testicular cancer	6.18e-05	0.000215	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Methotrexate—testicular cancer	6.13e-05	0.000214	CcSEcCtD
Venlafaxine—Decreased appetite—Epirubicin—testicular cancer	6.1e-05	0.000213	CcSEcCtD
Venlafaxine—Hypotension—Doxorubicin—testicular cancer	6.07e-05	0.000212	CcSEcCtD
Venlafaxine—Fatigue—Epirubicin—testicular cancer	6.05e-05	0.000211	CcSEcCtD
Venlafaxine—Constipation—Epirubicin—testicular cancer	6e-05	0.000209	CcSEcCtD
Venlafaxine—Pain—Epirubicin—testicular cancer	6e-05	0.000209	CcSEcCtD
Venlafaxine—Urticaria—Methotrexate—testicular cancer	5.96e-05	0.000208	CcSEcCtD
Venlafaxine—Body temperature increased—Methotrexate—testicular cancer	5.93e-05	0.000207	CcSEcCtD
Venlafaxine—Abdominal pain—Methotrexate—testicular cancer	5.93e-05	0.000207	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	5.91e-05	0.000206	CcSEcCtD
Venlafaxine—Insomnia—Doxorubicin—testicular cancer	5.87e-05	0.000205	CcSEcCtD
Venlafaxine—Paraesthesia—Doxorubicin—testicular cancer	5.83e-05	0.000203	CcSEcCtD
Venlafaxine—Dyspnoea—Doxorubicin—testicular cancer	5.79e-05	0.000202	CcSEcCtD
Venlafaxine—Feeling abnormal—Epirubicin—testicular cancer	5.78e-05	0.000202	CcSEcCtD
Venlafaxine—Somnolence—Doxorubicin—testicular cancer	5.77e-05	0.000201	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Epirubicin—testicular cancer	5.74e-05	0.0002	CcSEcCtD
Venlafaxine—Dyspepsia—Doxorubicin—testicular cancer	5.71e-05	0.000199	CcSEcCtD
Venlafaxine—Decreased appetite—Doxorubicin—testicular cancer	5.64e-05	0.000197	CcSEcCtD
Venlafaxine—Fatigue—Doxorubicin—testicular cancer	5.6e-05	0.000195	CcSEcCtD
Venlafaxine—Urticaria—Epirubicin—testicular cancer	5.57e-05	0.000194	CcSEcCtD
Venlafaxine—Pain—Doxorubicin—testicular cancer	5.55e-05	0.000194	CcSEcCtD
Venlafaxine—Constipation—Doxorubicin—testicular cancer	5.55e-05	0.000194	CcSEcCtD
Venlafaxine—Abdominal pain—Epirubicin—testicular cancer	5.55e-05	0.000193	CcSEcCtD
Venlafaxine—Body temperature increased—Epirubicin—testicular cancer	5.55e-05	0.000193	CcSEcCtD
Venlafaxine—Hypersensitivity—Methotrexate—testicular cancer	5.52e-05	0.000193	CcSEcCtD
Venlafaxine—Asthenia—Methotrexate—testicular cancer	5.38e-05	0.000188	CcSEcCtD
Venlafaxine—Feeling abnormal—Doxorubicin—testicular cancer	5.35e-05	0.000187	CcSEcCtD
Venlafaxine—NPY1R—lymph node—testicular cancer	5.31e-05	0.0733	CbGeAlD
Venlafaxine—Gastrointestinal pain—Doxorubicin—testicular cancer	5.31e-05	0.000185	CcSEcCtD
Venlafaxine—Pruritus—Methotrexate—testicular cancer	5.3e-05	0.000185	CcSEcCtD
Venlafaxine—Hypersensitivity—Epirubicin—testicular cancer	5.17e-05	0.00018	CcSEcCtD
Venlafaxine—Urticaria—Doxorubicin—testicular cancer	5.16e-05	0.00018	CcSEcCtD
Venlafaxine—Abdominal pain—Doxorubicin—testicular cancer	5.13e-05	0.000179	CcSEcCtD
Venlafaxine—Body temperature increased—Doxorubicin—testicular cancer	5.13e-05	0.000179	CcSEcCtD
Venlafaxine—Diarrhoea—Methotrexate—testicular cancer	5.13e-05	0.000179	CcSEcCtD
Venlafaxine—Asthenia—Epirubicin—testicular cancer	5.03e-05	0.000176	CcSEcCtD
Venlafaxine—Pruritus—Epirubicin—testicular cancer	4.96e-05	0.000173	CcSEcCtD
Venlafaxine—Dizziness—Methotrexate—testicular cancer	4.96e-05	0.000173	CcSEcCtD
Venlafaxine—Diarrhoea—Epirubicin—testicular cancer	4.8e-05	0.000167	CcSEcCtD
Venlafaxine—Hypersensitivity—Doxorubicin—testicular cancer	4.78e-05	0.000167	CcSEcCtD
Venlafaxine—Vomiting—Methotrexate—testicular cancer	4.77e-05	0.000166	CcSEcCtD
Venlafaxine—Rash—Methotrexate—testicular cancer	4.73e-05	0.000165	CcSEcCtD
Venlafaxine—Dermatitis—Methotrexate—testicular cancer	4.72e-05	0.000165	CcSEcCtD
Venlafaxine—Headache—Methotrexate—testicular cancer	4.7e-05	0.000164	CcSEcCtD
Venlafaxine—Asthenia—Doxorubicin—testicular cancer	4.66e-05	0.000162	CcSEcCtD
Venlafaxine—Dizziness—Epirubicin—testicular cancer	4.64e-05	0.000162	CcSEcCtD
Venlafaxine—Pruritus—Doxorubicin—testicular cancer	4.59e-05	0.00016	CcSEcCtD
Venlafaxine—Vomiting—Epirubicin—testicular cancer	4.46e-05	0.000156	CcSEcCtD
Venlafaxine—Nausea—Methotrexate—testicular cancer	4.45e-05	0.000155	CcSEcCtD
Venlafaxine—Diarrhoea—Doxorubicin—testicular cancer	4.44e-05	0.000155	CcSEcCtD
Venlafaxine—Rash—Epirubicin—testicular cancer	4.42e-05	0.000154	CcSEcCtD
Venlafaxine—Dermatitis—Epirubicin—testicular cancer	4.42e-05	0.000154	CcSEcCtD
Venlafaxine—Headache—Epirubicin—testicular cancer	4.4e-05	0.000153	CcSEcCtD
Venlafaxine—Dizziness—Doxorubicin—testicular cancer	4.29e-05	0.00015	CcSEcCtD
Venlafaxine—Nausea—Epirubicin—testicular cancer	4.17e-05	0.000145	CcSEcCtD
Venlafaxine—Vomiting—Doxorubicin—testicular cancer	4.13e-05	0.000144	CcSEcCtD
Venlafaxine—Rash—Doxorubicin—testicular cancer	4.09e-05	0.000143	CcSEcCtD
Venlafaxine—Dermatitis—Doxorubicin—testicular cancer	4.09e-05	0.000143	CcSEcCtD
Venlafaxine—Headache—Doxorubicin—testicular cancer	4.07e-05	0.000142	CcSEcCtD
Venlafaxine—Nausea—Doxorubicin—testicular cancer	3.86e-05	0.000135	CcSEcCtD
Venlafaxine—ABCG2—seminal vesicle—testicular cancer	3.81e-05	0.0526	CbGeAlD
Venlafaxine—SLC6A2—gonad—testicular cancer	3.45e-05	0.0476	CbGeAlD
Venlafaxine—SLC6A3—testis—testicular cancer	3.08e-05	0.0425	CbGeAlD
Venlafaxine—CYP2B6—gonad—testicular cancer	2.54e-05	0.0351	CbGeAlD
Venlafaxine—SLC6A2—testis—testicular cancer	2.49e-05	0.0343	CbGeAlD
Venlafaxine—ABCG2—female gonad—testicular cancer	2.24e-05	0.0309	CbGeAlD
Venlafaxine—ABCB1—embryo—testicular cancer	2e-05	0.0276	CbGeAlD
Venlafaxine—ABCG2—testis—testicular cancer	1.99e-05	0.0274	CbGeAlD
Venlafaxine—ABCB1—seminal vesicle—testicular cancer	1.88e-05	0.0259	CbGeAlD
Venlafaxine—CYP2B6—testis—testicular cancer	1.83e-05	0.0253	CbGeAlD
Venlafaxine—SLC6A2—lymph node—testicular cancer	1.8e-05	0.0249	CbGeAlD
Venlafaxine—CYP2D6—female gonad—testicular cancer	1.53e-05	0.0212	CbGeAlD
Venlafaxine—ABCG2—lymph node—testicular cancer	1.44e-05	0.0199	CbGeAlD
Venlafaxine—CYP2D6—testis—testicular cancer	1.36e-05	0.0188	CbGeAlD
Venlafaxine—ABCB1—gonad—testicular cancer	1.36e-05	0.0187	CbGeAlD
Venlafaxine—ABCB1—female gonad—testicular cancer	1.1e-05	0.0152	CbGeAlD
Venlafaxine—ABCB1—testis—testicular cancer	9.79e-06	0.0135	CbGeAlD
Venlafaxine—ABCB1—lymph node—testicular cancer	7.1e-06	0.0098	CbGeAlD
